COMBINATION OF SOMATOSTATIN ANALOGUES WITH VARIED SELECTIVITY WITH REGARD TO HUMAN SOMATOSTATIN RECEPTORS SUBTYPES Russian patent published in 2012 - IPC A61K38/31 A61P3/10 

FIELD: medicine, pharmaceutics.

SUBSTANCE: invention relates to the field of pharmacology and represents a combination for hyperglycaemia reduction and includes at least two different somatostatin (SRIF) analogues where one SRIF analogue is octreotide while the other SRIF analogue is pasireotide; every time the active ingredients are present in the composition in free form or in the form of a pharmaceutically acceptable salt, optionally - mixed with at least one pharmaceutically acceptable for joint, separate or sequential application.

EFFECT: invention ensures reduction of the side effect caused by pasireotide ie considerable hyperglycaemia reduction.

6 cl, 4 dwg